Possibilities of development of fibrinolytic activity with new and projected agents.
D000818:Animals; D001773:Blood Cells / Q000201:enzymology; D001920:Bradykinin / Q000627:therapeutic use; D005081:Exercise Therapy; D005341:Fibrinolysin / Q000627:therapeutic use; D005342:Fibrinolysis / Q000187:drug effects*; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D009539:Nicotinic Acids / Q000627:therapeutic use; D010102:Oxygen Inhalation Therapy; D011343:Procaine / Q000627:therapeutic use; D029002:Steam Bath; D013300:Streptokinase / Q000627:therapeutic use; D013806:Theophylline / Q000627:therapeutic use; D013927:Thrombosis / Q000628:therapy
D005343:Fibrinolytic Agents; D009539:Nicotinic Acids; D011343:Procaine; D013806:Theophylline; D013300:Streptokinase; D005341:Fibrinolysin; D001920:Bradykinin